Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated statements of changes in convertible preferred shares and shareholders' (deficit) equity

v3.23.1
Consolidated statements of changes in convertible preferred shares and shareholders' (deficit) equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019 45,786,714        
Beginning balance at Dec. 31, 2019 $ 96,025        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Preferred C Shares, net of issuance cost (in shares) 4,870,328        
Issuance of Preferred C Shares, net of issuance cost $ 39,785        
Ending balance (in shares) at Dec. 31, 2020 50,657,042        
Ending balance at Dec. 31, 2020 $ 135,810        
Beginning balance (in shares) at Dec. 31, 2019   13,669,287      
Beginning balance at Dec. 31, 2019 (129,233) $ 37 $ 18,846 $ 149 $ (148,265)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,656,994      
Exercise of stock options 1,442 $ 5 1,437    
Share-based compensation 4,800   4,800    
Deemed dividend to ordinary and preferred shareholders     825   (825)
Other comprehensive loss (73)     (73)  
Net loss (21,996)       (21,996)
Ending balance (in shares) at Dec. 31, 2020   15,326,281      
Ending balance at Dec. 31, 2020 $ (145,060) $ 42 25,908 76 (171,086)
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of Convertible Preferred Shares to Ordinary Shares (in shares) (50,657,042)        
Conversion of Convertible Preferred Shares to Ordinary Shares upon IPO $ (135,810)        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 1,301,233 1,311,587      
Exercise of stock options $ 1,222 $ 4 1,218    
Share-based compensation 11,171   11,171    
Conversion of convertible preferred shares to ordinary shares (in shares)   50,657,042      
Conversion of Convertible Preferred Shares to Ordinary Shares upon IPO 135,810 $ 136 135,674    
Issuance of shares in relation to initial public offering, net (in shares)   7,550,531      
Issuance of ordinary shares under the employee share purchase plan 150,666 $ 23 150,643    
Other comprehensive loss 84     84  
Net loss $ (68,979)       (68,979)
Ending balance (in shares) at Dec. 31, 2021 74,845,441 74,845,441      
Ending balance at Dec. 31, 2021 $ 84,914 $ 205 324,614 160 (240,065)
Ending balance (in shares) at Dec. 31, 2022 0        
Ending balance at Dec. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 911,307 1,230,823      
Exercise of stock options $ 2,034 $ 4 2,030    
Share-based compensation 16,987   16,987    
Issuance of shares in relation to initial public offering, net (in shares)   357,508      
Issuance of ordinary shares under the employee share purchase plan 2,083 $ 1 2,082    
Other comprehensive loss (527)     (527)  
Deferred costs in relation to initial public offering 121   121    
Net loss (83,661)       (83,661)
Ending balance (in shares) at Dec. 31, 2022   76,433,772      
Ending balance at Dec. 31, 2022 $ 21,951 $ 210 $ 345,834 $ (367) $ (323,726)